- 全部删除
- 您的购物车当前为空
我们很想知道您的意见反馈,所以我们在每个页面上都梳理出一个反馈按钮。
释放人工智能的新能量。轻松筛选海量数据库,让药物发现更快速,更敏捷,更高效
虚拟筛选流程
虚拟筛选是一种用于从化学空间中识别潜在活性化合物的技术,传统高通量筛选虽然全面,但识别活性化合物的概率低,且耗费的时间与成本高。而虚拟筛选提高了发现活性化合物的可能性,这使其成为一种更有效和更具成本效益的方法。以美国Structure Bioinformatics Inc. (SBI)提供的数据为例,平均每个新靶点需筛选10万个化合物,其命中率在0.1%~0.01%,而虚拟筛选的命中率可提高到5%~20%,可减少99.9%的费用。
来源 | 数字 | 特点 | 货期 |
---|---|---|---|
TargetMol库 | 种类繁多 | 化合物库多种多样 超过 800 个包含生物活性化合物和天然产物的文库,用于筛选精确靶点和信号通路 | 现货 |
TargetMol | 20K + | 靶点及生物活性信息清晰,规格灵活,TargetMol20K+适合药物重定位、细胞诱导、机制研究、靶点识别等 | 现货 |
Topscience数据库 | 26M + | 化合物都是Topscience生态链中的所有多样性化合物、天然化合物 | 快速购买 |
PLK1-SHCBP1 complex is involved in cell mitosis and promotes cancer, so it is of great significance to design inhibitors of PLK1-SHCBP1 complex. We constructed the 3D structure of SHCBP1 by Homologous Modeling, and predicted the binding mode of PLK1-SHCBP1 by Molecular Docking. Subsequently, 17,676 compounds (mainly including natural products and bioactive compounds) of Targetmol were screened by Virtual Screening. Forty candidate compounds were obtained with Artificial Selection. Finally TFBG (TSID: T4S0554) was selected, which is expected to be an effective method for the treatment of gastric cancer.
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.